Sale!

MT-TS2 Gene MERRFMELAS overlap syndrome MT-TS2 related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MT-TS2 gene MERRFMELAS overlap syndrome is a rare genetic disorder that combines features of two mitochondrial diseases: Myoclonic Epilepsy with Ragged Red Fibers (MERRF) and Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). This overlap syndrome is associated with mutations in the mitochondrial gene MT-TS2, which plays a crucial role in mitochondrial function and energy production. Individuals with this syndrome may exhibit a wide range of symptoms, including muscle weakness, seizures, stroke-like episodes, and other neurological and systemic complications.

To diagnose this complex condition, genetic testing is essential. At DNA Labs UAE, a specialized test is available to identify mutations in the MT-TS2 gene associated with the MERRFMELAS overlap syndrome. The test involves analyzing the patient’s DNA to detect specific genetic alterations that can confirm the diagnosis, allowing for appropriate management and treatment strategies to be implemented.

The cost of the MT-TS2 gene MERRFMELAS overlap syndrome genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the presence of the mutation. By opting for this test, patients and their families can gain valuable insights into their condition, enabling better-informed decisions regarding their health and care plans.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MT-TS2 Gene MERRFMELAS Overlap Syndrome MT-TS2 Related Genetic Test

Are you concerned about the possibility of having MT-TS2 gene MERRFMELAS overlap syndrome? DNA Labs UAE offers a genetic test specifically designed to analyze the MT-TS2 gene for any mutations or variants that may be present. This test can help in the diagnosis, prognosis, and management of individuals with MERRFMELAS overlap syndrome and other mitochondrial disorders caused by mutations in the MT-TS2 gene.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the MT-TS2 gene MERRFMELAS overlap syndrome test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by MT-TS2 gene MERRFMELAS overlap syndrome. This information will assist in the accurate interpretation of the test results and provide insights into the inheritance pattern.

Test Details

The MT-TS2 gene is a mitochondrial gene responsible for encoding the transfer RNA for serine 2 (tRNA-Ser2). Mutations in this gene can lead to a range of mitochondrial disorders, including MERRF (Myoclonic Epilepsy with Ragged Red Fibers) and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) overlap syndrome.

MERRF is characterized by symptoms such as myoclonus (involuntary muscle jerks), epilepsy, ataxia (lack of muscle coordination), and the presence of ragged red fibers when examining muscle tissue under a microscope. On the other hand, MELAS is characterized by a combination of symptoms including stroke-like episodes, encephalopathy (brain dysfunction), lactic acidosis (excessive lactic acid buildup), and muscle weakness.

The MT-TS2 related NGS Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the MT-TS2 gene for any mutations or variants. By identifying the specific genetic mutation in the MT-TS2 gene, this test can confirm the diagnosis of MERRF/MELAS overlap syndrome, provide information about the prognosis and inheritance pattern, and guide the management and treatment of affected individuals.

If you suspect that you or a family member may have MT-TS2 gene MERRFMELAS overlap syndrome, it is crucial to undergo the MT-TS2 related NGS Genetic Test for accurate diagnosis and appropriate medical intervention.

Test Name MT-TS2 Gene MERRFMELAS overlap syndrome MT-TS2 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TS2 Gene MERRF/MELAS overlap syndrome, MT-TS2 related NGS Genetic DNA Test gene MT-TS2
Test Details

MT-TS2 gene is a mitochondrial gene that encodes for the transfer RNA for serine 2 (tRNA-Ser2). Mutations in this gene can lead to a spectrum of mitochondrial disorders, including MERRF (Myoclonic Epilepsy with Ragged Red Fibers) and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) overlap syndrome.

MERRF is characterized by myoclonus (involuntary muscle jerks), epilepsy, ataxia (lack of muscle coordination), and ragged red fibers seen under microscopic examination of muscle tissue. MELAS is characterized by a combination of symptoms including stroke-like episodes, encephalopathy (brain dysfunction), lactic acidosis (buildup of lactic acid in the body), and muscle weakness.

MT-TS2 related NGS Genetic Test is a genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the MT-TS2 gene for any mutations or variants. This test helps in the diagnosis of MERRF/MELAS overlap syndrome and other mitochondrial disorders caused by mutations in the MT-TS2 gene.

By identifying the specific genetic mutation in the MT-TS2 gene, this test can confirm the diagnosis, provide information about the prognosis and inheritance pattern, and guide the management and treatment of the individual with MERRF/MELAS overlap syndrome.